SF-1 (Steroidogenic Factor 1, Ad4BP or NR5A1) is a member of the nuclear receptor family composed of a DNA-binding domain, a hinge region and a ligand-binding domain. 1 As a transcription factor, SF-1 binds to specific DNA sequences and activates the expression of its target genes. 2 These target genes are involved in steroidogenesis, reproduction, differentiation and sex determination in the adrenals, gonads and the brain. 1, 3 SF-1 regulates the development and differentiation of endocrine and reproductive organs. 4 Sf-1 null-mice die shortly after birth; their adrenal glands and gonads are absent due to the apoptosis of adrenogenital primordial cells during embryonic development. 5 Sf-1 heterozygous mice are impaired in adrenal growth following unilateral adrenalectomy. 6 Clinically, SF-1 mutations causing reduced transcriptional activity are associated with the disorder of sex development and sometimes adrenal insufficiency. 7 These studies indicate the requirement of adequate SF-1 activity for proper growth and differentiation of adrenals and gonads.
Contrary to SF-1 insufficiency, increased SF-1 dosage triggers adrenocortical cell proliferation. Sf-1 transgenic mice develop adrenal tumors, and increased SF-1 dosage causes hyper-proliferation of adrenocortical H295 cells. 8 Childhood adrenocortical tumors are also associated with increased copy number of SF-1 gene. 9 The growth-promoting property of SF-1 can be reversed by treating cells with SF-1 inverse agonists. 10 These studies demonstrate the importance of SF-1 dosage and activity in adrenal growth. Data from patients, mouse models and cell lines all suggest the requirement of SF-1 activity for its function in growth and differentiation, although the detailed mechanism by which SF-1 controls these processes is still unclear. Cell growth is a tightly controlled process regulated by many factors. One such machinery is the centrosome. Centrosome contains a pair of centrioles and the surrounding pericentriolar materials (PCM). Centrioles are composed of nine microtubule triplets with a-and b-tubulin heterodimer as the basic building block. The PCM contains many proteins including g-tubulin ring complex required for microtubules nucleation. In interphase, centrosomes are the primary microtubule organization center. During mitosis, centrosomes form asters that nucleate mitotic spindles for equal separation of chromosomes. 11 Besides, the centrosome can serve as a scaffold to anchor a variety of regulatory proteins, which also contribute to cell cycle progression. 12 Proper centrosome functions ensure faithful transmission of genetic information.
Centrosome homeostasis is required to maintain genetic fidelity during cell division. 13 Similar to chromosomes, centrosomes duplicate only once in each cell cycle.
14 If this duplication control is disrupted, centrosomes will be amplified. 15 Amplified centrosomes will cause multipolar mitosis and chromosome mis-segregation, resulting in genomic instability. 13, 16 The maintenance of centrosome homeostasis is an important issue for proper cell growth.
In the present report, we have studied the role of SF-1 in growth control and found SF-1 resided in the centrosome in addition to the nucleus. A centrosome localization signal (CLS) at a.a. 348-367 of SF-1 was identified. Overexpression of this CLS polypeptide prevented the accumulation of SF-1 and g-tubulin in the centrosome. We also found SF-1 depletion from adrenocortical Y1 cells caused centrosome over-duplication and subsequent genomic instability. Thus, we illustrated a novel function of SF-1 in maintaining centrosome homeostasis.
Result SF-1 depletion leads to reduced cell growth and aberrant mitosis. To study the function of SF-1 in cell growth, we used shRNA delivered into mouse adrenocortical Y1 cells by lentivirus to deplete SF-1 expression. A total of five different SF-1 shRNA sequences were tested. SF-1 shRNA #2 and #3 were most efficient in depleting SF-1 ( Figure 1a) . The effects of SF-1 depletion on Y1 cell growth were further examined. The number of Y1 cells depleted of SF-1 by shsf1 #2 and shsf1 #3 were significantly lower than those by control shluc (Figure 1b) . These results indicated that SF-1 participated in Y1 cell growth control.
To understand how SF-1 depletion caused reduction of cell numbers, we examined cell proliferation by measuring bromodeoxyuridine (BrdU) incorporation and apoptosis by detecting cleaved caspase 3. Five days after lentivirus infection, cell proliferation as measured by BrdU incorporation was decreased (Figures 1c and d) . Besides, apoptosis was increased as revealed by the higher levels of cleaved caspase 3 ( Figure 1e ). These results indicate that SF-1 depletion causes impaired cell growth by reducing cell proliferation and increasing apoptosis.
We further examined mitotic Y1 cells by immunofluorescence at five days after lentivirus infection (Figure 2A ). During mitosis, chromosomes from control luc cells lined up along the metaphase plate and bipolar spindle poles were detected by g-tubulin staining (Figure 2Ba ). But higher proportions of SF-1 depleted sf1 #2 and sf1 #3 cells contained disorganized chromosome that did not align on the metaphase plate with pseudo-bipolar (Figure 2Bb ) or multi-polar (Figure 2Bc ) spindle poles ( Figure 2C ). Enlarged nuclei ( Figure 2D ) were also detected in a greater fraction of SF-1-depleted cells ( Figure 2E ), and these cells with enlarged nuclei expressed a high level of senescence-associated b-galactosidase ( Figure 2F ). These results demonstrate that long-term SF-1 depletion leads to mitotic problems like formation of aberrant spindle poles, enlarged nuclei and eventually senescence, implying a role of SF-1 in maintaining genomic stability.
We examined SF-1-depleted cells in interphase using g-tubulin as a centrosome marker. Many g-tubulin spots were observed after SF-1 depletion ( Figure 2G ). The numbers of cells with multiple centrosomes were increased after SF-1 was depleted by shsf1 #2 and shsf1 #3 ( Figure 2H ), indicating that SF-1 depletion leads to formation of multiple centrosomes.
SF-1 depletion causes centrosome over-duplication. SF-1 depletion led to the formation of both mitotic defects and multiple centrosomes. To differentiate the primary cause of these defects, we examined cells at an earlier time point (two days after lentivirus infection) (Figure 3a) . Centrosome amplification was evident (Figure 3b ), but these cells did not have enlarged nuclear size (Figure 3c ) or multiple nuclei (Figure 3d ). These results imply that the immediate defect caused by SF-1 depletion is centrosome amplification, and mitotic defects should be the consequence caused by centrosome amplification.
Centrosome amplification can arise from centrosome fragmentation, cytokinetic failure or over-duplication. To examine whether the amplified centrosomes caused by SF-1 depletion were fragmented, the components of centriole and PCM were examined (Figure 3e ). All g-tubulin spots contained the centriolar marker centrin (upper panel) and a-tubulin (middle panel, treated with nocodazole). The results indicate that these amplified centrosomes are intact containing both centrioles and PCM.
To test the microtubule nucleating function of the centrosome, nocodazole was applied to depolymerize all microtubules. After removal of nocodazole allowing microtubule repolymerization, a-tubulin threads were detected extending from the base of g-tubulin spots, indicating that all these amplified centrosomes are capable of nucleating microtubule networks in vivo (lower panel). Thus, these amplified centrosomes retained the function to nucleate microtubules in interphase. To further examine the cause of centrosome amplification, we stained centrosomes with CEP170, which is present only in the mother centriole. 17 Only one CEP170 signal was detected in each control shluc cell. SF-1 depletion by shsf1 #2 or shsf1 #3 did not change the number of CEP170 signals per cell, despite the presence of multiple g-tubulin spots (Figures 3f and g ). The presence of a single mother centriole among many amplified centrosomes indicates that centrosome amplification caused by SF-1 deficiency is not due to cytokinetic failure, and is possibly due to centrosome over-duplication.
Centrosomes are duplicated during S phase under the control of CDK2 in coordination with DNA replication. 18 To further confirm if centrosome over-duplication occurred in SF-1-depleted cells, Y1 cells were arrested in S phase by treatment with hydroxyurea (HU) for 24 h to allow more time for centrosome reduplication. More shsf1 #3 cells had amplified centrosomes than control shluc cells (Figure 3h ). When treated with roscovitine, a CDK2 inhibitor, centrosome amplification induced by shsf1 #3 was blocked even in the presence of HU (Figure 3h ). These results show that centrosome amplification in SF-1 depleted Y1 cells is due to centrosome over-duplication, but not centrosome fragmentation or cytokinetic failure.
In addition to adrenocortical Y1 cells, one would wonder whether centrosomes in other types of cells were also controlled by SF-1. To test this, we transfected FLAG-SF-1 into osteosarcoma cell line U2OS (Supplementary Figure  S1A) . The population of FLAG-SF-1-transfected cells with multiple centrosomes was not different from that of EYFPtransfected control cells either before or after HU treatment (Supplementary Figure S1B) . Therefore, SF-1 does not affect centrosome numbers in U2OS cells.
Non-genomic function of SF-1 in maintaining centrosome homeostasis. To further confirm the effect of SF-1 on centrosome homeostasis, we tested whether exogenous SF-1 can rescue the centrosome defect. Y1 cells were first infected with lentivirus-expressing GFP or FLAG-tagged shRNAresistant SF-1 (SF-1 R , Supplementary Figure S2A ), cultured under neomycin selection until uninfected cells were dead, then infected again with shsf1 #3 lentivirus for five days. In these cells the endogenous SF-1 was efficiently depleted by shRNA, in contrast the level of exogenous SF-1 R was not affected (Figure 4a ). Cyp11a1, an SF-1 target, was also restored to a level similar to control shluc Y1 cells. The ability of SF-1 R to rescue centrosome amplification defect was examined. SF-1 depletion by shsf1 #3 caused centrosome amplification in a high percentage of GFPexpressing Y1 cells, but this number returned to the basal level when cells expressed SF-1 R (Figure 4b ). Besides this transient SF-1 R -expressing system, stable expression of SF-1 R in Y1 also led to a reduction of the fraction of cells with multiple centrosomes even though its endogenous SF-1 was depleted by shsf1 #3 (Supplementary Figure S2B) . The rescue of the centrosome amplification defect by SF-1 R demonstrates the function of SF-1 in preventing centrosome amplification.
To examine if the transcriptional activity of SF-1 is required to maintain centrosome homeostasis, we generated a lentivirus that expressed a mutant SF-1 without DNA-binding ability due to the replacement of its Gly35 by Glu (SF-1-G35E). 19 This G35E mutant was transcriptionally inactive, and when stably expressed in Y1 cells failed to induce Cyp11a1 expression (Figure 4a and Supplementary Figure  S2C) . It, however, rescued the centrosome defect induced by shsf1 #3 (Figure 4b ). This result indicates that the ability of SF-1 to prevent centrosome amplification is likely independent of its nuclear transcriptional activity.
We then determined if the cell growth delay caused by SF-1 depletion can be rescued by restoring SF-1 expression. Y1 cell clones stably expressing GFP, SF-1 R and transcriptiondefective FLAG-SF-1 (SF-1 R -G35E) with or without SF-1 depletion were tested (Figure 4c ). While control luc cells grew well, GFP-expressing cells depleted of SF-1 by sh #3 grew poorly. Wild-type SF-1 R significantly rescued the cell growth defect. The SF-1 R -G35E also partially restored cell growth caused by SF-1 depletion (Figure 4d ). This result suggests the involvement of transcription-independent function of SF-1 in maintaining cell growth in addition to the known transcriptiondependent function. 8 Centriolar localization of SF-1. SF-1 is present in the nucleus. By immunofluorescence analysis we noticed a spot stained with SF-1 antibody adjacent to the nucleus of mouse adrenocortical Y1 cells (Figure 5a) . A monoclonal anti-SF-1 (7D5) antibody also detected the same staining pattern ( Supplementary Figures S3A and B) . This spot was colocalized with g-tubulin, indicating it was a centrosome (Figure 5a and Supplementary Figure S3B) . The same SF-1 staining was also observed in the centrosome of H295 cells Figure S3C) . The localization of SF-1 to the centrosome was further investigated by centrosome fractionation using sucrose gradient centrifugation (Figure 5b ). SF-1 co-fractionated with g-tubulin, further confirming the centrosome localization of SF-1 in Y1 cells.
The location of SF-1 within the centrosome was further examined by co-staining with the centriole markers a-tubulin (Figure 5c , upper panel, with nocodazole treatment) and centrin ( Figure 5c, lower panel) . The colocalization of SF-1 with centriole markers indicates the presence of SF-1 in the centriole.
In addition to endogenous SF-1, transfected FLAG-tagged SF-1 was detected in the nucleus and centrosome using FLAG antibodies (Figure 5d ). Sucrose gradient fractionation of the centrosome preparation showed that FLAG-SF-1 and g-tubulin co-sedimented in the same fractions between 50% and 40% of sucrose (Figures 5e and f) . The absence of Mitochondrial Complex II and nuclear hnRNPA1 signals in the centrosome fractions excluded the possibility of nuclear and mitochondrial contaminations. Thus, our data show that SF-1 is localized to the centriole in addition to the nucleus.
Identification of SF-1 centrosomal localization signal. To identify the signal peptide that targets SF-1 to the centrosome, SF-1 was truncated into various fragments and fused with GFP for easy subcellular identification by green fluorescence. All those SF-1 fragments containing a.a. 348-367 were present in peri-nuclear dots (arrows in Figure 6a ) plus occasional nuclear or cytoplasmic distribution. Those peri-nuclear dots colocalized with g-tubulin (Figure 6b and Supplementary Figure S4A) . Thus, we identified a CLS of SF-1 as a.a. 348-367. The ability of CLS to localize in the centrosome was further confirmed by fractionation of cell lysate and centrosome purification. GFP-CLS, but not GFP, was present in the centrosome fraction together with g-tubulin, confirming centrosome localization of this peptide (Figure 6c ). Looking at this CLS polypeptide more closely, we found that it has repeated sequences of hydrophobic residues containing Leu or Val (Figure 6d ). These amino acids were mutated to Ala, creating a 9A mutant. GFP fused to the wild-type CLS, but not the 9A mutant, was localized to peri-nuclear centrosomal dots, indicating the importance of these amino acids in targeting SF-1 to the centrosome. We have mutated SF-1 at three, six, or nine residues of this CLS (Supplementary Figure S4B) . All these mutants, however, lost transcriptional activities (Supplementary Figure S4B) , thus precluding the separation of transcriptional activity from centrosome targeting.
To examine the function of this CLS, we overexpressed SF-1 CLS. Y1 cells expressing GFP-CLS had reduced SF-1 staining in the centrosome. When compared with untransfected cells or cells expressing GFP alone, these GFP-CLS cells also had reduced g-tubulin signal in the centrosome (Figures 7a and b) . Microtubule regrowth after nocodazole treatment was also impaired after CLS overexpression (Figures 7c and d) , suggesting compromised centrosome function. The displacement of SF-1 and g-tubulin from the centrosome by this CLS implies that these two proteins may share common features in centrosome localization. Indeed when sequences of SF-1 CLS and g-tubulin from different species were aligned, a consensus motif was detected with conserved Val and Lue (Figure 7e ), implying similar centrosome-targeting machineries that recognize this CLS. Thus, this CLS in SF-1 or a related region in g-tubulin appears to target SF-1 and g-tubulin to the centrosome for normal composition and function of centrosomes.
Discussion
In this study, we have investigated the function of SF-1 in maintaining centrosome homeostasis and genomic stability. We found that SF-1 was located in both nuclei and centrosomes, and SF-1 regulated centrosome homeostasis without invoking its transcriptional activity. We also identified a CLS sequence that targeted SF-1 to the centrosome. Overexpression of this CLS reduced accumulation of SF-1 and g-tubulin in the centrosome. Our results reveal a new function of SF-1 in regulating centrosome homeostasis possibly through a non-genomic function.
Requirement of SF-1 in maintaining genomic stability and cell growth. In this report, we demonstrated the importance of SF-1 in maintaining adrenocortical Y1 cell growth. Our results are consistent with the reported role of SF-1 in adrenocortical cell proliferation. 8 The function of SF-1 in centrosome regulation can at least partly explain the requirement of SF-1 in supporting steroidogenic cell growth by maintaining centrosome homeostasis and genomic stability. Furthermore, SF-1 overexpression in transgenic mice triggers cancer formation. 8 Cancer has been tightly linked to centrosome abnormality, as amplified centrosomes cause mitotic defects like multipolar mitosis, chromosome mis-segregation or cytokinetic defects, contributing to genomic instability. 13, 16, 20 Although the centrosome number in SF-1-overexpressing tumor has not been examined, it is conceivable that centrosome defects would exist as cancer cells are often associated with genomic instability caused by centrosomal defects.
The reduced cell number in vitro that we observed after SF-1 depletion correlates well with that in Sf-1-null mice. The adrenogenital primordial cells of Sf-1-null mice undergo apoptosis at E11.5-E12.5, 5 but the cause of this apoptotic death is still not understood. Our observation of apoptosis and centrosome amplification caused by SF-1 deficiency may explain why Sf-1-null adrenogenital primordial cells die, as centrosome amplification causes aberrant mitosis and subsequent cell cycle arrest or cell death. 13, 21 It would be interesting to examine whether the adrenogenital primordial cells of these Sf-1-null mice contain multiple centrosomes before they die. This experiment will not be easy because one has to catch the short time window at around E11.5 when these progenitor cells are dying.
SF-1 is a tissue-specific factor present mainly in the adrenals and gonads. Our results showed that SF-1 controlled centrosome numbers of only adrenocortical Y1 cells but not . Identical residues are shown in green, and similar ones in red. Species abbreviations: Bt, Bos taurus; Mm, Mus musculus; Dm, Drosophila melanogaster; Sp, Schizosaccharomyces pombe; Rn, Rattus norvegicus; Tg, Taeniopygia guttata. The putative consensus sequence is shown below. F, hydrophobic amino acid osteosarcoma U2OS cells. This result is consistent with the cell type specificity of SF-1. Growth properties from different cell types often vary. Each growing cell has its own cell typespecific factors that regulate cell cycle progression. For example, MyoD, a myoblast-specific factor, regulates the growth and differentiation of only muscle cells, 22 while GATA1 regulates the growth and differentiation of erythroid cells. 23 SF-1 is expressed mainly in the adrenal and gonad to regulate the growth of steroidogenic tissues. Our results illustrate a way by which a cell-specific protein controls the growth of a particular cell lineage. It would be of interest to examine the centrosomes from other cells and whether their growth is controlled by cell type-specific centrosomal proteins.
Role of SF-1 in centrosome homeostasis. SF-1 participates in the control of adrenogonadal cell growth. 8 In the current studies, we found SF-1 also regulated centrosome homeostasis, and the G35E mutant of SF-1 retained the ability to control centrosome numbers. SF-1-G35E is a mutant impaired in DNA binding and transcription activation. 24 Therefore, the transcriptional activity of SF-1 is likely not required for the control of centrosome homeostasis.
In addition to the transcriptionally impaired G35E mutation, we also examined CLS mutations of SF-1. Unfortunately all these CLS mutants lost their transcriptional activities. The CLS of SF-1 is located in a conserved region at the ligandbinding domain presumably important for transcription; this is probably why the abolishment of centrosome targeting also affects the transcriptional activity of SF-1. Despite this difficulty, centrosomal proteins often contribute to centrosome homeostasis. 12, 25 The characterization of SF-1 as a centrosomal protein provides a possible mechanism for this nongenomic SF-1 function. Our results reveal a novel function of SF-1 in maintaining centrosome homeostasis possibly through its centrosomal, but not nuclear, localization.
In our results, SF-1 depletion-induced centrosome amplification is strongly enhanced in the presence of HU and can be reversed by treating with roscovitine, suggesting the uncoupling of centrosome duplication cycle and DNA duplication cycle upon SF-1 depletion. Recent report describes that centrosomes can still duplicate in the prolonged G1 phase induced by mimosine treatment without significant rise in CDK2 activity, providing another pathway for centrosome duplication. 26 However, this situation probably does not occur in SF-1-depleted Y1 cells because centrosome amplification caused by SF-1 depletion can be rescued by CDK2 inhibitor roscovitine.
Functional importance of SF-1 centrosome localization signal. In this report we identified a 20-amino-acid CLS sequence located at the ligand-binding domain that could target SF-1 to the centrosome. Overexpression of this CLS resulted in reduced accumulation of SF-1 and g-tubulin in the centrosome. This CLS has similar properties as other centrosome-targeting domains from proteins like AKAP450, Cyclin A, Cyclin E, which displace their endogenous proteins from centrosomes when overexpressed. [27] [28] [29] [30] These CLS domains interact with scaffold proteins important for centrosome localization and functions of their endogenous proteins.
The CLS from SF-1 can displace both SF-1 and g-tubulin from the centrosome, indicating that both proteins may share similar centrosome-targeting machineries. g-Tubulin exists as complexes along with other proteins. 31 Centrosomal localization of g-tubulin complexes is mediated by multiple proteins such as pericentrin, AKAP450/CG-NAP, NEDD1/GCP-WD, ninein and ninein-like proteins through interaction with g-tubulin complex components. 31 The presence of shared amino acids in SF-1-CLS and g-tubulin suggests the existence of common interacting proteins. SF-1-CLS overexpression may block the recruitment of g-tubulin to centrosomes by competing for unidentified binding proteins. Searching for the SF-1-CLS interacting proteins can give us more hints on this phenomenon. The other possibility is that CLS in SF-1 might be shared by other proteins functioning in the centrosomal recruitment of g-tubulin; thus, overexpression of SF-1-CLS may compete away those proteins involved in g-tubulin recruitment. It would be interesting to identify those proteins that may contain similar functional domains like SF-1-CLS.
Materials and Methods
The experimental details for plasmids and their construction, cell culture, derivation of stable protein overexpression cells, cell growth assay, antibodies, NCBI accession number of the genes for sequence alignment, lentivirus-mediated RNA Interference and cDNA expression are provided in the Supplementary information.
Centrosome purification. Centrosome was purified from asynchronous Y1 cells by sucrose gradient ultra-centrifugation as described previously. 32 Briefly, cells were treated with nocodazole (10 mg/ml) and cytochalasin B (5 mg/ml) for 60 min at 371C, then lysed in cold lysis buffer containing 10 mM Tris-HCl, pH 8.0, 0.5% NP-40 and 0.1% b-mercaptoethanol. After centrifugation at 2000 Â g, the supernatant was overlaid on a 50% sucrose (w/w) cushion layer and centrifuged again at 10 000 Â g for 1 h. Supernatant was removed and the concentrated centrosomes were separated by centrifugation over a discontinuous sucrose gradient containing 65, 50 and 40% sucrose (w/w) at 35 000 Â g. Samples (400 ml/fraction) were collected from the bottom of the tube.
Immuno-fluorescence microscopy. To visualize SF-1, g-tubulin, centrin, and CEP170 by immunofluorescence, cells were harvested by direct fixation with ice-cold methanol for 5 min followed by antibodies staining. To visualize centrosomal FLAG-SF-1 by anti-FLAG and depolymerized a-tubulin by anti-atubulin staining, cells were pretreated with 30 mM nocodazole on ice for 1 h to depolymerize microtubule networks, followed by extraction with saponin (20 ng/ml) for 2 min before fixation. After fixation and blocking with 5% BSA, cells were incubated with antibodies overnight at 41C followed by incubation with Alexa 488, Alexa 546, or Alexa 633 conjugated secondary antibodies (Invitrogen, Carlsbad, CA, USA) for 1 h in the dark.
The nuclei were stained with 4, 6-diamino-2-phenylindole (DAPI, 0.1 mg/ ml). Fluorescence was detected with an AxioImager Z1 fluorescence microscope or an LSM 510 confocal microscope (Zeiss, Zurich, Switzerland). The number of centrosomes and centrioles from more than one hundred cells was counted under the microscope. To measure nuclear size, DAPI signals were quantified using the MetaMorph software (Universal Imaging Corporation, West Chester, PA, USA). Student's t-test was used to analyze experiments within two groups as indicated. All data are expressed as the mean ± S.D. from at least three independent experiments.
To identify SF-1 CLS, various SF-1 fragments fused to GFP were transfected into Y1 cells for 6 h followed by paraformaldehyde fixation, then analyzed by direct fluorescence examination of GFP and/or immunofluorescence detection of g-tubulin.
In CLS overexpression experiment, cells were transfected with GFP or GFP-CLS plasmids for 18 h followed by fixation in ice-cold methanol and co-staining with SF-1 and g-tubulin antibodies. Only GFP-positive cells without obvious aggregation were selected for quantitation to avoid the side effect caused by protein aggregation. The centrosomal SF-1 or g-tubulin signals in the transfected cells were compared with
